Troosters, T., R. Casaburi, R. Gosselink, and M. Decramer. 2005. Pulmonary rehabilitation in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 172(1):19-38.

van Gestel, Y. R., S. E. Hoeks, D. D. Sin, V. Huzeir, H. Stam, F. W. Mertens, R. T. van Domburg, J. J. Bax, and D. Poldermans. 2009. COPD and cancer mortality: The influence of statins. Thorax 64(11):963-967.

Vestbo, J., and P. Lange. 2002. Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? American Journal of Respiratory and Critical Care Medicine 166(3):329-332.

Vincken, W., J. A. van Noord, A. P. M. Greefhorst, T. A. Bantje, S. Kesten, L. Korducki, and P. J. G. Cornelissen. 2002. Improved health outcomes in patients with COPD during 1 yr’s treatment with tiotropium. European Respiratory Journal 19(2):209-216.

Wennberg, J. E., E. S. Fisher, T. A. Stukel, and S. M. Sharp. 2004. Use of Medicare claims data to monitor provider-specific performance among patients with severe chronic illness. Health Affairs (Millwood) (Suppl):5-18.

Werner, R. M., and E. T. Bradlow. 2006. Relationship between Medicare’s hospital compare performance measures and mortality rates. JAMA: The Journal of the American Medical Association 296(22):2694-2702.

WHO (World Health Organization). 2008. Global strategy for diagnosis, management, and prevention of COPD. http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=989 (accessed February 3, 2008).

Williams, S. C., S. P. Schmaltz, D. J. Morton, R. G. Koss, and J. M. Loeb. 2005. Quality of care in U.S. hospitals as reflected by standardized measures, 2002-2004. New England Journal of Medicine 353(3):255-264.

Wilt, T. J., D. Niewoehner, C. Kim, R. L. Kane, A. Linabery, J. Tacklind, R. Macdonald, and I. Rutks. 2005. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). Evidence Report/Technology Assessment (Summary)(121):1-7.

Wong, K. W., F. K. Y. Wong, and M. F. Chan. 2005. Effects of nurse-initiated telephone follow-up on self-efficacy among patients with chronic obstructive pulmonary disease. Journal of Advanced Nursing 49(2):210-222.

Xu, W., J.-P. Collet, S. Shapiro, Y. Lin, T. Yang, R. W. Platt, C. Wang, and J. Bourbeau. 2008. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. American Journal of Respiratory and Critical Care Medicine 178(9):913-920.

Xu, W., J.-P. Collet, S. Shapiro, Y. Lin, T. Yang, C. Wang, and J. Bourbeau. 2010. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. European Respiratory Journal 35(5):1022-1030.

Yarger, S., K. Rascati, K. Lawson, J. Barner, and R. Leslie. 2008. Analysis of predictive value of four risk models in Medicaid recipients with chronic obstructive pulmonary disease in texas. Clinical Therapeutics 30:1051-1057.

Yohannes, A. M., and M. J. Connolly. 2004. Pulmonary rehabilitation programmes in the UK: A national representative survey. Clinical Rehabilitation 18(4):444-449.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement